Tarsus Pharmaceuticals (TARS) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free TARS Stock Alerts $37.00 +2.96 (+8.70%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Brokeragesamericanbankingnews.com - May 13 at 2:26 AMWilliam Blair Comments on Tarsus Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:TARS)americanbankingnews.com - May 13 at 1:14 AMTarsus Pharmaceuticals, Inc. to Post Q2 2024 Earnings of ($1.10) Per Share, Lifesci Capital Forecasts (NASDAQ:TARS)americanbankingnews.com - May 13 at 1:14 AMEarnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimatesfinance.yahoo.com - May 12 at 10:42 AMBarclays Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $60.00americanbankingnews.com - May 12 at 4:32 AMOppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61.00americanbankingnews.com - May 12 at 3:57 AMTarsus Pharmaceuticals (NASDAQ:TARS) Trading 5.8% Higher After Analyst Upgradeamericanbankingnews.com - May 11 at 2:22 AMTarsus Pharmaceuticals (NASDAQ:TARS) Given New $60.00 Price Target at Barclaysmarketbeat.com - May 10 at 6:18 PMTarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 10 at 8:29 AMAnalyst Ratings For Tarsus Pharmaceuticalsmarkets.businessinsider.com - May 9 at 5:28 PMTarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conferenceglobenewswire.com - May 9 at 5:00 PMTarsus Pharmaceuticals, Inc: Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievementsfinanznachrichten.de - May 9 at 12:27 PMTarsus Pharmaceuticals GAAP EPS of -$1.01 beats by $0.18, revenue of $27.61M beats by $9.71Mmsn.com - May 9 at 12:27 PMTarsus Pharmaceuticals (NASDAQ:TARS) Sets New 1-Year High at $42.50marketbeat.com - May 9 at 11:00 AMVivo Capital LLC Has $36.13 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - May 9 at 10:39 AMTarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...finance.yahoo.com - May 9 at 7:26 AMTARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 8 at 10:04 PMTarsus Reports First Quarter 2024 Financial Results and Recent Business Achievementsglobenewswire.com - May 8 at 4:05 PMTarsus Pharmaceuticals earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 7 at 7:41 PMTarsus Pharmaceuticals (TARS) to Release Quarterly Earnings on Wednesdaymarketbeat.com - May 2 at 10:00 AMTarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024globenewswire.com - May 1 at 5:00 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN), Organon (OGN) and Exelixis (EXEL)markets.businessinsider.com - May 1 at 8:37 AMabrdn plc Purchases New Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - April 30 at 4:59 AMMaáza Martinlatimes.com - April 28 at 8:51 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Vivo Capital LLCmarketbeat.com - April 27 at 9:40 PMAnalysts Conflicted on These Healthcare Names: Amneal Pharmaceuticals (AMRX) and Community Health (CYH)markets.businessinsider.com - April 25 at 10:18 AMBioPharma Credit to loan USD100 million to Tarsus Pharmaceuticalslse.co.uk - April 24 at 8:59 AMBuy Rating Affirmed for Tarsus Pharmaceuticals Amidst Strategic Debt Refinancing and Strong Financial Outlookmarkets.businessinsider.com - April 24 at 3:59 AMTarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakonglobenewswire.com - April 23 at 8:30 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock Holdings Trimmed by Allspring Global Investments Holdings LLCmarketbeat.com - April 20 at 5:14 AMInsider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%finance.yahoo.com - April 19 at 8:16 AMQ1 2024 EPS Estimates for Tarsus Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:TARS)marketbeat.com - April 19 at 8:16 AMVanguard Group Inc. Has $27.58 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - April 13 at 4:30 AMTarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 5.2%marketbeat.com - April 12 at 2:51 PMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.1%marketbeat.com - April 11 at 4:01 PMWall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Knowfinance.yahoo.com - April 8 at 2:09 PMScientists share trial results for new tick-repelling drug for humans: 'An amazing opportunity'msn.com - April 6 at 2:18 AMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.3%marketbeat.com - March 28 at 7:27 PMTarsus Pharmaceuticals executive sells over $130k in company stockinvesting.com - March 21 at 8:19 PMTarsus Pharmaceuticals exec sells over $135k in stockinvesting.com - March 21 at 8:19 PMBryan Wahl Sells 4,436 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stockinsidertrades.com - March 20 at 6:52 AMInsider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) General Counsel Sells 4,436 Shares of Stockmarketbeat.com - March 19 at 8:14 PMPill Targeting Tick-Induced Lyme Disease Shows Promise in Human Trialsmsn.com - March 18 at 2:35 AMTARS Apr 2024 25.000 callfinance.yahoo.com - March 16 at 2:01 PMTARS Apr 2024 17.500 putfinance.yahoo.com - March 16 at 1:17 AMTARS Apr 2024 12.500 callfinance.yahoo.com - March 16 at 1:17 AMTarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 6.9%marketbeat.com - March 15 at 12:37 PMAnalysts Offer Insights on Healthcare Companies: ProQR (PRQR) and Crinetics Pharmaceuticals (CRNX)markets.businessinsider.com - March 13 at 7:29 PMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.7%marketbeat.com - March 11 at 12:44 PMTarsus Pharmaceuticals (NASDAQ:TARS) Price Target Increased to $44.00 by Analysts at Jefferies Financial Groupmarketbeat.com - March 7 at 8:20 AM Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Email Address Dave Ramsey Shocks Millions With US Dollar Lunacy (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE TARS Media Mentions By Week TARS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TARS News Sentiment▼0.550.58▲Average Medical News Sentiment TARS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TARS Articles This Week▼253▲TARS Articles Average Week Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 4D Molecular Therapeutics News Vir Biotechnology News Neumora Therapeutics News ADMA Biologics News Cullinan Oncology News Scholar Rock News BioCryst Pharmaceuticals News Inhibrx News Autolus Therapeutics News Fusion Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TARS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThis 1 Biotech Stock has been shocking the marketsHuge AlertsDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
